Global Pediatric Drugs and Vaccines Market 2018: Industry, Sales, Demand, Analysis, Opportunities and Forecast to 2025

 Published: Jul-2018 |  Format: PDF | YQ Research |  Number of pages: 115

<pre>This report studies the global Pediatric Drugs and Vaccines market status and forecast, categorizes the global Pediatric Drugs and Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The global Pediatric Drugs and Vaccines market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturers covered in this report Merck & Co., Inc. (USA) Abbott Laboratories (USA) Amgen, Inc. (USA) Eli Lilly and Company (USA) F. Hoffmann-La Roche Ltd (Switzerland) Genentech, Inc. (USA) GlaxoSmithKline plc. (UK) Janssen Biologics B.V. (USA) Actelion Pharmaceuticals AstraZeneca Plc. (UK) Boehringer Ingelheim GmbH (Germany) Bristol-Myers Squibb Company (USA) Allergan, Inc. (USA) Novartis AG (Switzerland) Novo Nordisk A/S (Denmark) Pfizer, Inc. (USA) Sanofi S.A (France) Shionogi Inc. (USA) Shire Pharmaceuticals Group Plc. (UK) Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan India Southeast Asia Other regions (Central & South America, Middle East & Africa) We can also provide the customized separate regional or country-level reports, for the following regions: North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Rest of Asia-Pacific Europe Germany France UK Italy Spain Russia Rest of Europe Central & South America Brazil Argentina Rest of South America Middle East & Africa Saudi Arabia Turkey Rest of Middle East & Africa On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into by Vaccine Types Diphtheria Influenza Hepatitis Pneumococcal Diseases Meningococcal Diseases Mumps Others by Disease Types Roseola Tetanus Whooping Cough Allergy and Respiratory Diseases Malaria Anemia Other By Application, the market can be split into Newborn Infant Child The study objectives of this report are: To analyze and study the global Pediatric Drugs and Vaccines capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025); Focuses on the key Pediatric Drugs and Vaccines manufacturers, to study the capacity, production, value, market share and development plans in future. Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. To define, describe and forecast the market by type, application and region. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Pediatric Drugs and Vaccines are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Pediatric Drugs and Vaccines Manufacturers Pediatric Drugs and Vaccines Distributors/Traders/Wholesalers Pediatric Drugs and Vaccines Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: Regional and country-level analysis of the Pediatric Drugs and Vaccines market, by end-use. Detailed analysis and profiles of additional market players.</pre>
<pre>Table of Contents Global Pediatric Drugs and Vaccines Market Professional Survey Report 2018 1 Industry Overview of Pediatric Drugs and Vaccines 1.1 Definition and Specifications of Pediatric Drugs and Vaccines 1.1.1 Definition of Pediatric Drugs and Vaccines 1.1.2 Specifications of Pediatric Drugs and Vaccines 1.2 Classification of Pediatric Drugs and Vaccines 1.2.1 Diphtheria 1.2.2 Influenza 1.2.3 Hepatitis 1.2.4 Pneumococcal Diseases 1.2.5 Meningococcal Diseases 1.2.6 Mumps 1.2.7 Others 1.3 Applications of Pediatric Drugs and Vaccines 1.3.1 Newborn 1.3.2 Infant 1.3.3 Child 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 Europe 1.4.3 China 1.4.4 Japan 1.4.5 Southeast Asia 1.4.6 India 2 Manufacturing Cost Structure Analysis of Pediatric Drugs and Vaccines 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Pediatric Drugs and Vaccines 2.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines 2.4 Industry Chain Structure of Pediatric Drugs and Vaccines 3 Technical Data and Manufacturing Plants Analysis of Pediatric Drugs and Vaccines 3.1 Capacity and Commercial Production Date of Global Pediatric Drugs and Vaccines Major Manufacturers in 2017 3.2 Manufacturing Plants Distribution of Global Pediatric Drugs and Vaccines Major Manufacturers in 2017 3.3 R&D Status and Technology Source of Global Pediatric Drugs and Vaccines Major Manufacturers in 2017 3.4 Raw Materials Sources Analysis of Global Pediatric Drugs and Vaccines Major Manufacturers in 2017 4 Global Pediatric Drugs and Vaccines Overall Market Overview 4.1 2013-2018E Overall Market Analysis 4.2 Capacity Analysis 4.2.1 2013-2018E Global Pediatric Drugs and Vaccines Capacity and Growth Rate Analysis 4.2.2 2017 Pediatric Drugs and Vaccines Capacity Analysis (Company Segment) 4.3 Sales Analysis 4.3.1 2013-2018E Global Pediatric Drugs and Vaccines Sales and Growth Rate Analysis 4.3.2 2017 Pediatric Drugs and Vaccines Sales Analysis (Company Segment) 4.4 Sales Price Analysis 4.4.1 2013-2018E Global Pediatric Drugs and Vaccines Sales Price 4.4.2 2017 Pediatric Drugs and Vaccines Sales Price Analysis (Company Segment) 5 Pediatric Drugs and Vaccines Regional Market Analysis 5.1 North America Pediatric Drugs and Vaccines Market Analysis 5.1.1 North America Pediatric Drugs and Vaccines Market Overview 5.1.2 North America 2013-2018E Pediatric Drugs and Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.1.3 North America 2013-2018E Pediatric Drugs and Vaccines Sales Price Analysis 5.1.4 North America 2017 Pediatric Drugs and Vaccines Market Share Analysis 5.2 Europe Pediatric Drugs and Vaccines Market Analysis 5.2.1 Europe Pediatric Drugs and Vaccines Market Overview 5.2.2 Europe 2013-2018E Pediatric Drugs and Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.2.3 Europe 2013-2018E Pediatric Drugs and Vaccines Sales Price Analysis 5.2.4 Europe 2017 Pediatric Drugs and Vaccines Market Share Analysis 5.3 China Pediatric Drugs and Vaccines Market Analysis 5.3.1 China Pediatric Drugs and Vaccines Market Overview 5.3.2 China 2013-2018E Pediatric Drugs and Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.3.3 China 2013-2018E Pediatric Drugs and Vaccines Sales Price Analysis 5.3.4 China 2017 Pediatric Drugs and Vaccines Market Share Analysis 5.4 Japan Pediatric Drugs and Vaccines Market Analysis 5.4.1 Japan Pediatric Drugs and Vaccines Market Overview 5.4.2 Japan 2013-2018E Pediatric Drugs and Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.4.3 Japan 2013-2018E Pediatric Drugs and Vaccines Sales Price Analysis 5.4.4 Japan 2017 Pediatric Drugs and Vaccines Market Share Analysis 5.5 Southeast Asia Pediatric Drugs and Vaccines Market Analysis 5.5.1 Southeast Asia Pediatric Drugs and Vaccines Market Overview 5.5.2 Southeast Asia 2013-2018E Pediatric Drugs and Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.5.3 Southeast Asia 2013-2018E Pediatric Drugs and Vaccines Sales Price Analysis 5.5.4 Southeast Asia 2017 Pediatric Drugs and Vaccines Market Share Analysis 5.6 India Pediatric Drugs and Vaccines Market Analysis 5.6.1 India Pediatric Drugs and Vaccines Market Overview 5.6.2 India 2013-2018E Pediatric Drugs and Vaccines Local Supply, Import, Export, Local Consumption Analysis 5.6.3 India 2013-2018E Pediatric Drugs and Vaccines Sales Price Analysis 5.6.4 India 2017 Pediatric Drugs and Vaccines Market Share Analysis 6 Global 2013-2018E Pediatric Drugs and Vaccines Segment Market Analysis (by Type) 6.1 Global 2013-2018E Pediatric Drugs and Vaccines Sales by Type 6.2 Different Types of Pediatric Drugs and Vaccines Product Interview Price Analysis 6.3 Different Types of Pediatric Drugs and Vaccines Product Driving Factors Analysis 6.3.1 Diphtheria Growth Driving Factor Analysis 6.3.2 Influenza Growth Driving Factor Analysis 6.3.3 Hepatitis Growth Driving Factor Analysis 6.3.4 Pneumococcal Diseases Growth Driving Factor Analysis 6.3.5 Meningococcal Diseases Growth Driving Factor Analysis 6.3.6 Mumps Growth Driving Factor Analysis 6.3.7 Others Growth Driving Factor Analysis 7 Global 2013-2018E Pediatric Drugs and Vaccines Segment Market Analysis (by Application) 7.1 Global 2013-2018E Pediatric Drugs and Vaccines Consumption by Application 7.2 Different Application of Pediatric Drugs and Vaccines Product Interview Price Analysis 7.3 Different Application of Pediatric Drugs and Vaccines Product Driving Factors Analysis 7.3.1 Newborn of Pediatric Drugs and Vaccines Growth Driving Factor Analysis 7.3.2 Infant of Pediatric Drugs and Vaccines Growth Driving Factor Analysis 7.3.3 Child of Pediatric Drugs and Vaccines Growth Driving Factor Analysis 8 Major Manufacturers Analysis of Pediatric Drugs and Vaccines 8.1 Merck & Co., Inc. (USA) 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Product A 8.1.2.2 Product B 8.1.3 Merck & Co., Inc. (USA) 2017 Pediatric Drugs and Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Merck & Co., Inc. (USA) 2017 Pediatric Drugs and Vaccines Business Region Distribution Analysis 8.2 Abbott Laboratories (USA) 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Product A 8.2.2.2 Product B 8.2.3 Abbott Laboratories (USA) 2017 Pediatric Drugs and Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Abbott Laboratories (USA) 2017 Pediatric Drugs and Vaccines Business Region Distribution Analysis 8.3 Amgen, Inc. (USA) 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Product A 8.3.2.2 Product B 8.3.3 Amgen, Inc. (USA) 2017 Pediatric Drugs and Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Amgen, Inc. (USA) 2017 Pediatric Drugs and Vaccines Business Region Distribution Analysis 8.4 Eli Lilly and Company (USA) 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Product A 8.4.2.2 Product B 8.4.3 Eli Lilly and Company (USA) 2017 Pediatric Drugs and Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Eli Lilly and Company (USA) 2017 Pediatric Drugs and Vaccines Business Region Distribution Analysis 8.5 F. Hoffmann-La Roche Ltd (Switzerland) 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Product A 8.5.2.2 Product B 8.5.3 F. Hoffmann-La Roche Ltd (Switzerland) 2017 Pediatric Drugs and Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 F. Hoffmann-La Roche Ltd (Switzerland) 2017 Pediatric Drugs and Vaccines Business Region Distribution Analysis 8.6 Genentech, Inc. (USA) 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Product A 8.6.2.2 Product B 8.6.3 Genentech, Inc. (USA) 2017 Pediatric Drugs and Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Genentech, Inc. (USA) 2017 Pediatric Drugs and Vaccines Business Region Distribution Analysis 8.7 GlaxoSmithKline plc. (UK) 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Product A 8.7.2.2 Product B 8.7.3 GlaxoSmithKline plc. (UK) 2017 Pediatric Drugs and Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 GlaxoSmithKline plc. (UK) 2017 Pediatric Drugs and Vaccines Business Region Distribution Analysis 8.8 Janssen Biologics B.V. (USA) 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Product A 8.8.2.2 Product B 8.8.3 Janssen Biologics B.V. (USA) 2017 Pediatric Drugs and Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Janssen Biologics B.V. (USA) 2017 Pediatric Drugs and Vaccines Business Region Distribution Analysis 8.9 Actelion Pharmaceuticals 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Product A 8.9.2.2 Product B 8.9.3 Actelion Pharmaceuticals 2017 Pediatric Drugs and Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Actelion Pharmaceuticals 2017 Pediatric Drugs and Vaccines Business Region Distribution Analysis 8.10 AstraZeneca Plc. (UK) 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.2.1 Product A 8.10.2.2 Product B 8.10.3 AstraZeneca Plc. (UK) 2017 Pediatric Drugs and Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 AstraZeneca Plc. (UK) 2017 Pediatric Drugs and Vaccines Business Region Distribution Analysis 8.11 Boehringer Ingelheim GmbH (Germany) 8.12 Bristol-Myers Squibb Company (USA) 8.13 Allergan, Inc. (USA) 8.14 Novartis AG (Switzerland) 8.15 Novo Nordisk A/S (Denmark) 8.16 Pfizer, Inc. (USA) 8.17 Sanofi S.A (France) 8.18 Shionogi Inc. (USA) 8.19 Shire Pharmaceuticals Group Plc. (UK) 9 Development Trend of Analysis of Pediatric Drugs and Vaccines Market 9.1 Global Pediatric Drugs and Vaccines Market Trend Analysis 9.1.1 Global 2018-2025 Pediatric Drugs and Vaccines Market Size (Volume and Value) Forecast 9.1.2 Global 2018-2025 Pediatric Drugs and Vaccines Sales Price Forecast 9.2 Pediatric Drugs and Vaccines Regional Market Trend 9.2.1 North America 2018-2025 Pediatric Drugs and Vaccines Consumption Forecast 9.2.2 Europe 2018-2025 Pediatric Drugs and Vaccines Consumption Forecast 9.2.3 China 2018-2025 Pediatric Drugs and Vaccines Consumption Forecast 9.2.4 Japan 2018-2025 Pediatric Drugs and Vaccines Consumption Forecast 9.2.5 Southeast Asia 2018-2025 Pediatric Drugs and Vaccines Consumption Forecast 9.2.6 India 2018-2025 Pediatric Drugs and Vaccines Consumption Forecast 9.3 Pediatric Drugs and Vaccines Market Trend (Product Type) 9.4 Pediatric Drugs and Vaccines Market Trend (Application) 10 Pediatric Drugs and Vaccines Marketing Type Analysis 10.1 Pediatric Drugs and Vaccines Regional Marketing Type Analysis 10.2 Pediatric Drugs and Vaccines International Trade Type Analysis 10.3 Traders or Distributors with Contact Information of Pediatric Drugs and Vaccines by Region 10.4 Pediatric Drugs and Vaccines Supply Chain Analysis 11 Consumers Analysis of Pediatric Drugs and Vaccines 11.1 Consumer 1 Analysis 11.2 Consumer 2 Analysis 11.3 Consumer 3 Analysis 11.4 Consumer 4 Analysis 12 Conclusion of the Global Pediatric Drugs and Vaccines Market Professional Survey Report 2017 Methodology Analyst Introduction Data Source</pre>
Please submit the below form, to get more about this report:
Indicates required fields

Please fill your details below, to receive sample report:
Indicates required fields



Latest News

Dec-2018 |Electrical & Electronic

Six Flags Has Challenged The Toughest Biometric Privacy Law Of The US

It was 2008 when Illinois released a law that after a decade stays as the toughest biometric privacy standard in the country.  The BIPA (Biometric Information Privacy Act) impose tough rules on how the firms are able to gather sensitive infor ...

Dec-2018 |Other

Ohio Became The First State To Accept Taxes From Businesses In Bitcoin

For Long, there is been a lot of uncertainty in terms of legalities in the United States about the cryptocurrency, but Ohio took a step ahead. Recently, it has become the first state to accept Bitcoin to pay the taxes. As noted by the WSJ (Wall St ...

Jan-2018 |Electrical & Electronic

Study Claims That Mobile Apps Enhance Mental Health Thus Fueling The Global Smartphone Application Market

People undergoing mental health issues can reinforce their psychological well-being via mobile apps, a new survey claimed. The study, posted in the journal JMIR Mental Health, claimed that users who grapple with emotional and mental health issues ...

Jan-2018 |Medical & Health

Government Controlling Drugs And Prices Impacting Pharmaceuticals Market

The central government is preparing to curb the prices of combine drugs, which include 14 types of drugs. These drugs are used in the treatment of diseases such as high blood pressure, sugar, and cholesterol. The Nationa ...

Jan-2018 |ICT and Media

Two lakh Job In IT Sector Depicting Solid Growth In The Market

Last year, there was little interference for jobs in India but the scenario of jobs looks better in 2018. This year, there is hope for more than two lakh jobs in the information technology sector.

According to data, the Indian employment ...